Immunocore Holdings plc (IMCR)
USD 28.26
(-3.88%)
USD 28.26
(-3.88%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 249.42 Million | 143.73 Million | 26.52 Million | 30.11 Million | 25.66 Million | 23.65 Million |
| Cost of Revenue | 1.03 Million | 454 Thousand | 73.22 Million | 74.8 Million | 99.99 Million | - |
| Gross Profit | 248.39 Million | 143.28 Million | -46.7 Million | -44.69 Million | -74.32 Million | 23.65 Million |
| Operating Expenses | 308.04 Million | 182.89 Million | 161.68 Million | 119.4 Million | 144.17 Million | 117.73 Million |
| Selling, General and Administrative Expenses | 144.49 Million | 93.72 Million | 88.39 Million | 45.74 Million | 44.18 Million | 34.15 Million |
| Research and Development Expenses | 163.54 Million | 89.17 Million | 73.22 Million | 74.8 Million | 99.99 Million | 83.57 Million |
| Other Expenses | - | -3000.00 | 57 Thousand | -1.14 Million | 185 Thousand | 5.6 Million |
| Cost and Expenses | 309.07 Million | 183.34 Million | 161.68 Million | 119.4 Million | 144.17 Million | 117.73 Million |
| Operating Income | -59.64 Million | -39.6 Million | -135.16 Million | -86.19 Million | -118.32 Million | -93.45 Million |
| Interest Expense | 5.15 Million | 7.69 Million | 5.81 Million | 3.1 Million | 3.79 Million | 842 Thousand |
| Income Tax Expense | -5.6 Million | -2.92 Million | -9.4 Million | -13.26 Million | -22.25 Million | -16.54 Million |
| Earnings before Tax | -60.89 Million | -44.14 Million | -140.92 Million | -87.36 Million | -126.18 Million | -88.17 Million |
| Net Income | -55.28 Million | -41.22 Million | -131.52 Million | -74.09 Million | -103.93 Million | -71.63 Million |
| Earnings Per Share Basic | -1.13 | -0.90 | -3.10 | -2.33 | -3.81 | -2.62 |
| Earnings Per Share Diluted | -1.13 | -0.90 | -3.00 | -2.33 | -3.81 | -2.62 |
| Weighted Average Shares Outstanding | 48.88 Million | 45.71 Million | 42.48 Million | 31.78 Million | 27.3 Million | 27.3 Million |
| Weighted Average Shares Outstanding (Diluted) | 48.88 Million | 45.71 Million | 43.86 Million | 31.78 Million | 27.3 Million | 27.3 Million |
| Gross Margin | 1.00 | 1.00 | -1.76 | -1.48 | -2.90 | 1.00 |
| EBIT Margin | -0.24 | -0.25 | -5.09 | -2.51 | -4.20 | -3.42 |
| Profit Margin | -0.22 | -0.29 | -4.96 | -2.46 | -4.05 | -3.03 |
| EBITDA | -59.64 Million | -38.35 Million | -166.71 Million | -102.58 Million | -113.18 Million | -86.74 Million |
| Earnings Before Tax Margin | -0.24 | -0.28 | -5.10 | -2.86 | -4.61 | -3.95 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 75.4 Million | 70.5 Million | 249.42 Million | 105.63 Million | 62.62 Million | 60.48 Million |
| Cost of Revenue | 1.7 Million | 246 Thousand | 1.03 Million | -247 Thousand | 267.58 Thousand | 1.12 Million |
| Gross Profit | 73.69 Million | 70.25 Million | 248.39 Million | 105.88 Million | 62.35 Million | 59.36 Million |
| Operating Expenses | 89.71 Million | 96.74 Million | 308.04 Million | 131.78 Million | 51.89 Million | 82.02 Million |
| Selling, General and Administrative Expenses | 38.63 Million | 39.28 Million | - | 57.13 Million | 13.36 Million | 45.59 Million |
| Research and Development Expenses | 51.07 Million | 57.45 Million | - | 74.65 Million | 38.53 Million | 36.42 Million |
| Other Expenses | 4.43 Million | -190 Thousand | -897 Thousand | - | - | - |
| Cost and Expenses | 91.41 Million | 96.99 Million | 309.07 Million | 131.53 Million | 52.16 Million | 83.14 Million |
| Operating Income | -16.01 Million | -26.49 Million | -59.64 Million | -25.79 Million | -850.19 Thousand | -19.97 Million |
| Interest Expense | 3.76 Million | 3.23 Million | 5.15 Million | 337 Thousand | 1.98 Million | 1.98 Million |
| Income Tax Expense | 1.48 Million | 357 Thousand | -5.6 Million | -5.84 Million | -175.14 Thousand | 191.21 Thousand |
| Earnings before Tax | -10.13 Million | -24.07 Million | -60.89 Million | -32.26 Million | 2.14 Million | -17.63 Million |
| Net Income | -11.61 Million | -24.43 Million | -55.28 Million | -26.41 Million | 2.31 Million | -17.82 Million |
| Earnings Per Share Basic | -0.23 | -0.49 | - | -0.54 | 0.05 | -0.37 |
| Earnings Per Share Diluted | -0.23 | -0.49 | - | -0.54 | 0.05 | -0.37 |
| Weighted Average Shares Outstanding | 50.01 Million | 49.87 Million | 48.88 Million | 48.88 Million | 54.15 Million | 48.69 Million |
| Weighted Average Shares Outstanding (Diluted) | 50.01 Million | 49.87 Million | 48.88 Million | 48.88 Million | 54.15 Million | 48.69 Million |
| Gross Margin | 0.98 | 1.00 | 1.00 | 1.00 | 1.00 | 0.98 |
| EBIT Margin | -0.06 | -0.25 | - | -0.18 | 0.27 | -0.28 |
| Profit Margin | -0.15 | -0.35 | -0.22 | -0.25 | 0.04 | -0.29 |
| EBITDA | -4.86 Million | -17.42 Million | - | -18.73 Million | 17.09 Million | -16.67 Million |
| Earnings Before Tax Margin | -0.21 | -0.38 | -0.24 | -0.24 | -0.01 | -0.33 |
3025
LEV
0A26
GMN
002880
BLRX